News & Stories

Immerse yourself in the fascinating world of a leading science and technology company. Explore the latest news from the media center and stay up-to-date with our upcoming events.

On the war in Ukraine

Statement by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany, on behalf of the Executive Board.

Read here

Latest News

View all news
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Delivers Strong First Quarter

    Merck KGaA, Darmstadt, Germany, achieved strong results in the first quarter of 2022. Net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter.

    2022/05/12

  2. Press Releases

    Science Based Targets initiative (SBTi) Confirms Contribution of Merck KGaA ...

    Merck KGaA, Darmstadt, Germany, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targets initiative (SBTi) has now confirmed that the company’s targets ...

    2022/05/06

  3. Press Releases

    MilliporeSigma Announces Investment of Approximately € 100 Million to Accelerate ...

    MilliporeSigma today announced the signing of an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone.

    2022/04/29

Get the latest news!

If you are interested in getting frequent company updates via email, feel free to subscribe to our press release service.
Subscribe

Our company at a glance

Our passion for science and technology is what drives our 58,000 employees in 66 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live.

Enjoy exploring

Key figures

Our excellent performance is measure and shown by several key figures, more information are stored in our investors section.

  • 19bn

    Net sales €19.7 billion

  • 6.1bn

    EBITDA pre €6.1 billion

  • 60K

    Around 60,300 Employees

Upcoming Events

View All Events

ASCO 2022

We look forward to sharing the latest innovations from our oncology research, as we work to transform patient outcomes and make a meaningful difference in the lives of people affected by cancer.